Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob George

Showing results (631-640 of 976) with videos related to

Pageof 98
Sort By:
The International Journal on Drug Policy|April 1, 2025
Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, AustraliaShane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
Gut Microbes|March 22, 2024
Using a human colonoid-derived monolayer to study bacteriophage translocationHuu Thanh Le, Alicia Fajardo Lubian, Bethany Bowring, et al.
Heart Rhythm|November 19, 2011
Renin-angiotensin system blockers are associated with reduced mortality and heart failure hospitalization in patients paced for complete atrioventricular blockDouglas H J Elder, Chim C Lang, Sushma Rekhraj, et al.
Journal of the American College of Cardiology|September 3, 2013
Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophyBenjamin R Szwejkowski, Stephen J Gandy, Sushma Rekhraj, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2024
Lipoprotein (a) in the Full Spectrum of Metabolic Dysfunction-associated Steatotic Liver Disease: Evidence From Histologically and Genetically Characterized CohortsHong Fan, Matina Kouvari, Geltrude Mingrone, et al.
Cost Effectiveness and Resource Allocation : C/E|February 20, 2026
Economic evaluations of the primary prevention programs for viral hepatitis-related liver disease and liver cancer: a systematic literature reviewMilena Lewandowska, Shenghan Cai, Shalini Wijekulasuriya, et al.
International Journal of Molecular Sciences|July 15, 2026
Integrated Plasma and Tissue Lipid Profiling Demonstrates a Distinctive Metabolic Profile in MAFLD-Associated Non-Cirrhotic Hepatocellular CarcinomaFatema Safri, Russell Pickford, Yikun Xu, et al.
The British Journal of Nutrition|July 24, 2015
Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot studyHelen M Parker, Helen T O'Connor, Shelley E Keating, et al.
Clinical Chemistry|August 2, 2005
Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infectionLeon A Adams, Max Bulsara, Enrico Rossi, et al.
Journal of Paediatrics and Child Health|June 9, 2009
Costs of managing conditions associated with obesity among Australian teenagersMichael L Booth, Timothy Dobbins, Robert Aitken, et al.
Pageof 98

Showing results (631-640 of 976) with videos related to

Sort By:
Pageof 98
The International Journal on Drug Policy|April 1, 2025
Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, AustraliaShane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
Gut Microbes|March 22, 2024
Using a human colonoid-derived monolayer to study bacteriophage translocationHuu Thanh Le, Alicia Fajardo Lubian, Bethany Bowring, et al.
Heart Rhythm|November 19, 2011
Renin-angiotensin system blockers are associated with reduced mortality and heart failure hospitalization in patients paced for complete atrioventricular blockDouglas H J Elder, Chim C Lang, Sushma Rekhraj, et al.
Journal of the American College of Cardiology|September 3, 2013
Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophyBenjamin R Szwejkowski, Stephen J Gandy, Sushma Rekhraj, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2024
Lipoprotein (a) in the Full Spectrum of Metabolic Dysfunction-associated Steatotic Liver Disease: Evidence From Histologically and Genetically Characterized CohortsHong Fan, Matina Kouvari, Geltrude Mingrone, et al.
Cost Effectiveness and Resource Allocation : C/E|February 20, 2026
Economic evaluations of the primary prevention programs for viral hepatitis-related liver disease and liver cancer: a systematic literature reviewMilena Lewandowska, Shenghan Cai, Shalini Wijekulasuriya, et al.
International Journal of Molecular Sciences|July 15, 2026
Integrated Plasma and Tissue Lipid Profiling Demonstrates a Distinctive Metabolic Profile in MAFLD-Associated Non-Cirrhotic Hepatocellular CarcinomaFatema Safri, Russell Pickford, Yikun Xu, et al.
The British Journal of Nutrition|July 24, 2015
Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot studyHelen M Parker, Helen T O'Connor, Shelley E Keating, et al.
Clinical Chemistry|August 2, 2005
Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infectionLeon A Adams, Max Bulsara, Enrico Rossi, et al.
Journal of Paediatrics and Child Health|June 9, 2009
Costs of managing conditions associated with obesity among Australian teenagersMichael L Booth, Timothy Dobbins, Robert Aitken, et al.
Pageof 98